Volatile Compounds in Actinomycete Communities: A New Tool for Biosynthetic Gene Cluster Activation, Cooperative Growth Promotion, and Drug Discovery

Cells. 2022 Nov 5;11(21):3510. doi: 10.3390/cells11213510.

Abstract

The increasing appearance of multiresistant pathogens, as well as emerging diseases, has highlighted the need for new strategies to discover natural compounds that can be used as therapeutic alternatives, especially in the genus Streptomyces, which is one of the largest producers of bioactive metabolites. In recent years, the study of volatile compounds (VOCs) has raised interest because of the variety of their biological properties in addition to their involvement in cell communication. In this work, we analyze the implications of VOCs as mediating molecules capable of inducing the activation of biosynthetic pathways of bioactive compounds in surrounding Actinomycetes. For this purpose, several strains of Streptomyces were co-cultured in chamber devices that allowed VOC exchange while avoiding physical contact. In several of those strains, secondary metabolism was activated by VOCs emitted by companion strains, resulting in increased antibiotic production and synthesis of new VOCs. This study shows a novel strategy to exploit the metabolic potential of Actinomycetes as well as emphasizes the importance of studying the interactions between different microorganisms sharing the same ecological niche.

Keywords: Streptomyces; biosynthetic potential; rumycins; secondary metabolites; volatile compounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actinobacteria* / genetics
  • Biosynthetic Pathways / genetics
  • Drug Discovery
  • Multigene Family
  • Streptomyces* / genetics
  • Streptomyces* / metabolism

Grants and funding

This research was funded by the Spanish Ministry of Science, Innovation and Universities, projects number MCIU-19-RTI2018-093562-B-I00 and PRE2019-089448 (to J.A.S and CO) and MCI-21-PID2020-113062RB-100 (to C.M.)